StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.88−0.00 (-0.26%)

Close on Nov 19, 2026Market cap $8.35MP/E –Yield –

Cellectar Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Cellectar Biosciences

Cellectar Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cellectar Biosciences figures

See a number that looks wrong?